Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Cough in IPF”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT02502097
What this trial is testing

Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)

Who this might be right for
Idiopathic Pulmonary FibrosisCough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 51
Testing effectiveness (Phase 2)Ended earlyNCT03864328
What this trial is testing

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Who this might be right for
Persistent Cough in IPFChronic CoughIPF
Respivant Sciences GmbH 108

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation